search
Back to results

Lokal Cold Application in Nitroglycerin-Induced Headache (NIH)

Primary Purpose

Headache

Status
Unknown status
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
Cold Application
Sponsored by
Yasemin Kalkan Uğurlu
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Headache focused on measuring Cryotherapy, Headache, Nitrates,

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • The patient's volunteerism to participate in the research,
  • Over the age of 18,
  • Being conscious,
  • Any analgesic, NSAID, triptan etc. Not taking antimigren drugs or opioids,
  • No cold allergies.

Exclusion Criteria:

  • Difficulty in communicating (speaking, perception, language, comprehension problems),
  • Vision and / or hearing loss,
  • Having a cold allergy.
  • Blood pressure above 150/90 mm / Hg.

Sites / Locations

  • Nuray EncRecruiting
  • Yasemin Kalkan UğurluRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control

experimental group

Arm Description

No application will be made to patients in this group. Routine patient care will be provided. After the patients who develop pain are recorded, the application will be made with a cold application bandage.

Patients in this group will be applied cold application with cold application bandage for 20 minutes as soon as the infusion begins.

Outcomes

Primary Outcome Measures

Headache
The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain." The distance between 'no pain' and the mark then defines the subject's pain.

Secondary Outcome Measures

Full Information

First Posted
December 23, 2020
Last Updated
September 2, 2021
Sponsor
Yasemin Kalkan Uğurlu
Collaborators
Istanbul University - Cerrahpasa (IUC)
search

1. Study Identification

Unique Protocol Identification Number
NCT04707586
Brief Title
Lokal Cold Application in Nitroglycerin-Induced Headache (NIH)
Official Title
The Effect of Lokal Cold Application in Nitroglycerin-Induced Headache
Study Type
Interventional

2. Study Status

Record Verification Date
September 2021
Overall Recruitment Status
Unknown status
Study Start Date
December 15, 2020 (Actual)
Primary Completion Date
January 15, 2022 (Anticipated)
Study Completion Date
March 15, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Yasemin Kalkan Uğurlu
Collaborators
Istanbul University - Cerrahpasa (IUC)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The study was planned to evaluate the effect of local cold application on headache severity in individuals who received intravenous nitroglycerin treatment, which mostly causes headache due to its vasoditator effect. It is thought that the results to be obtained may provide evidence for the development of patient care guidelines.
Detailed Description
The study was planned to evaluate the effect of local cold application on headache severity in individuals who received intravenous nitroglycerin treatment, which mostly causes headache due to its vasoditator effect. Inclusion criteria; The patient's volunteerism to participate in the research, Over the age of 18, Being conscious, Any analgesic, NSAID, triptan etc. Not taking antimigren drugs or opioids, No cold allergies. Exclusion Criteria; Difficulty in communicating (speaking, perception, language, comprehension problems), Vision and / or hearing loss, Having a cold allergy. Purpose and Type of Research: This research was planned as a quasi-experimental, two-group, pretest-posttest study to determine the effect of local cold application on headache in individuals treated with intravenous NTG, which mostly causes headache due to its vasodilator effect. Place and Time of the Study It will be carried out in Ordu State Hospital Coronary Intensive Care Unit between 15 December 2020 - 15 December November 2021. Research Population and Sample The universe of the study is planned to be composed of all patients who were hospitalized in Ordu State Hospital Coronary Intensive Care Unit between December 2020 and December 2021 and received intravenous nitroglycerine treatment. The sample of the study will be the patients who meet the sample selection criteria and are willing to participate in the study. The research sample will consist of experimental and control groups. Experiment 1:Local cold application was applied to the patients with the help of the applicator during the first 20 minutes of the nitroglycerin infusion. The patient was followed up during the cold application, after the procedure, the patient was evaluated in detail using the Patient Follow-up Form and VAS, and his questions were answered. The patient was given detailed information about the application before the procedure. Experiment 2: The patients were evaluated in detail using the Patient Follow-up Form and VAS for the first 12 hours of the infusion. Local cold application was applied for 20 minutes with the help of the applicator to the patients who developed headache. Immediately after the cold application, it was evaluated in detail using the Patient Follow-up Form and VAS. The groups were compared according to the data obtained. Power analysis (G*Power 3.1.9.2) was performed to determine the sample size of the study. As a result of the analysis; In the evaluation made according to headache severity, the sample size determined for Power:0.80, β:0.20 and α:0.05 is a minimum of 14 patients for each group. However, to increase the reliability of the study and considering that there may be patients who could leave the study during the study, the total number of samples was determined as 70, 35 in the experimental 1 group and 35 in the experimental 2 group. Data Collection Method Individuals who meet the criteria for inclusion in the sampling will be informed about the purpose, content and method of the research, and after the randomization process, experimental and control groups will be formed by obtaining the necessary written permission from those who agree to participate in the study. The research will consist of 2 groups as Experiment 1(Group of Local Cold Application at the Beginning of Infusion) and Experiment 2 (The Group Not Applying Local Cold at the Beginning of Infusion) Data will be collected by the researcher. Within the scope of the research, the patients in the experimental group who used the cold application bandage will be informed about the use of the bandage. Patient Information Form, Patient Follow-up Form and Visual Pain Perception Scale will be used to evaluate the sociodemographic, disease, treatment and pain level of all patients participating in the study prior to nitroglycerin infusion. A cold application bandage will be attached to the experimental 1 group and local cold application will be applied to the patient for the first 20 minutes of the nitroglycerine infusion. After 20 minutes, the bandage will be removed from the patient and the cold application will be terminated. The patient will be followed during the cold application, and the questions of the patient will be answered after the procedure. Immediately after the cold application, the patient's headache will be evaluated in detail using the Visual Pain Perception Scale and the Patient Follow-up Form. Patients in the experimental 2 group who develop headaches will be evaluated in detail using the Visual Pain Perception Scale and the Patient Follow-up Form, a cold application bandage will be worn and local cold application will be performed for 20 minutes. Immediately after the cold application, it will be evaluated in detail again using the Visual Pain Perception Scale and Patient Monitoring Form. In this way, the preventive and therapeutic effect of local cold application will be evaluated in patients receiving intravenous nitroglycerin treatment. Groups will be compared according to the data obtained.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Headache
Keywords
Cryotherapy, Headache, Nitrates,

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The quasi-experimental, two-group, pretest-posttest study
Masking
Care Provider
Allocation
Randomized
Enrollment
70 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
No application will be made to patients in this group. Routine patient care will be provided. After the patients who develop pain are recorded, the application will be made with a cold application bandage.
Arm Title
experimental group
Arm Type
Experimental
Arm Description
Patients in this group will be applied cold application with cold application bandage for 20 minutes as soon as the infusion begins.
Intervention Type
Other
Intervention Name(s)
Cold Application
Intervention Description
Created by the researcher; A bandage with 3 pieces of 13x10 cm cold gel and a cold gel container in which they are placed will be used, which can be adjusted according to the head circumference of the patient between 60-80 cm in length. The ability of the cold gel cups of the bandage to be moved on the bandage will allow comfortable cold application to the patient's bilateral frontotemporal and occipital areas at the same time. After waiting for 20 minutes in the freezer part of the refrigerator, the temperature and temperature of the gels applied and the cold application area before and after each application will be measured and recorded. An Infrared Non-Contact Food Thermometer will be used for temperature measurement of cold gel packs, and an Infrared Non-Contact Thermometer device will be used for temperature measurement of the cold application area.
Primary Outcome Measure Information:
Title
Headache
Description
The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain." The distance between 'no pain' and the mark then defines the subject's pain.
Time Frame
30 minutes, 3.,6., 9. and 12. hours after nitroglycerin infusion starts

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: The patient's volunteerism to participate in the research, Over the age of 18, Being conscious, Any analgesic, NSAID, triptan etc. Not taking antimigren drugs or opioids, No cold allergies. Exclusion Criteria: Difficulty in communicating (speaking, perception, language, comprehension problems), Vision and / or hearing loss, Having a cold allergy. Blood pressure above 150/90 mm / Hg.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yasemin K Uğurlu, MSCN
Phone
05465674652
Email
yasemin_kalkan24@hotmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Nuray K Enç, Professör
Phone
05337261618
Email
nurayenc@yahoo.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yasemin K Uğurlu
Organizational Affiliation
Ordu Üniversitesi
Official's Role
Principal Investigator
Facility Information:
Facility Name
Nuray Enc
City
Istanbul
Country
Turkey
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nuray Enc, Prof. Dr.
Phone
+90 5337261618
Email
nurayenc@gmail.com
Facility Name
Yasemin Kalkan Uğurlu
City
Ordu
ZIP/Postal Code
52200
Country
Turkey
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yasemin K Uğurlu
Phone
05465674652
Email
yasemin_kalkan24@hotmail.com

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The study protocol will be shared after the study is finished.
IPD Sharing Time Frame
Data will become available towards the end of 2022 and, it can be used for 1 year.
IPD Sharing Access Criteria
IPD Sharing will be make only for research.
Citations:
PubMed Identifier
23901394
Citation
Sprouse-Blum AS, Gabriel AK, Brown JP, Yee MH. Randomized controlled trial: targeted neck cooling in the treatment of the migraine patient. Hawaii J Med Public Health. 2013 Jul;72(7):237-41.
Results Reference
background
PubMed Identifier
20728068
Citation
Demir Y, Khorshid L. The effect of cold application in combination with standard analgesic administration on pain and anxiety during chest tube removal: a single-blinded, randomized, double-controlled study. Pain Manag Nurs. 2010 Sep;11(3):186-96. doi: 10.1016/j.pmn.2009.09.002. Epub 2010 May 31.
Results Reference
background
PubMed Identifier
22082021
Citation
Ertug N, Ulker S. The effect of cold application on pain due to chest tube removal. J Clin Nurs. 2012 Mar;21(5-6):784-90. doi: 10.1111/j.1365-2702.2011.03955.x. Epub 2011 Nov 15.
Results Reference
background
PubMed Identifier
28283812
Citation
Fraser F, Matsuzawa Y, Lee YSC, Minen M. Behavioral Treatments for Post-Traumatic Headache. Curr Pain Headache Rep. 2017 May;21(5):22. doi: 10.1007/s11916-017-0624-x.
Results Reference
result
PubMed Identifier
17173113
Citation
Ucler S, Coskun O, Inan LE, Kanatli Y. Cold Therapy in Migraine Patients: Open-label, Non-controlled, Pilot Study. Evid Based Complement Alternat Med. 2006 Dec;3(4):489-93. doi: 10.1093/ecam/nel035. Epub 2006 Jun 15.
Results Reference
result

Learn more about this trial

Lokal Cold Application in Nitroglycerin-Induced Headache (NIH)

We'll reach out to this number within 24 hrs